Background <p>Due to the widespread and irrational use of antibiotics, the emergence and prevalence of carbapenem-resistant <i>Klebsiella pneumoniae</i> (<i>K. pneumoniae</i>) have become a major challenge in controlling bacterial infections in hospitals. The <i>bla</i><sub><i>KPC−2</i></sub> gene located on mobile genetic elements has further complicated the control of resistant bacteria transmission.</p> Results <p>In this study, <i>K. pneumoniae</i> strains were isolated from blood cultures of patients. Using the Kirby-Bauer disk diffusion method, we found carbapenem resistance heterogeneity. The resistant subpopulation KPTA-R1 and the sensitive subpopulation KPTA-S1 were purified. Whole-genome sequencing revealed that the <i>bla</i><sub><i>KPC−2</i></sub> gene in KPTA-R1 was located on an IncFII plasmid (pKPC-R), within a composite transposon (PCTs) formed by two direct repeats of IS<i>26</i> elements. The structure was identified as IS<i>26</i>-<i>RecA</i>-IS<i>Kpn27</i>-<i>bla</i><sub><i>KPC−2</i></sub>-IS<i>Kpn6</i>-IS<i>26</i>. However, in KPTA-S1, a similar plasmid, pAR-S, lacked this segment. Sequence comparison analysis indicates that the deletion of this <i>bla</i><sub><i>KPC−2</i></sub> encoding sequence in this IncFII plasmid is associated with transposition activity mediated by IS<i>26</i>. Multi-sequence comparison of the plasmids showed that the IS<i>26</i> transposon facilitated the sequence polymorphism of these plasmids.</p> Conclusion <p>This study reveals the key role of IS<i>26</i>-mediated transposition activity, through homologous recombination, in the emergence of carbapenem resistance heterogeneity in clinical <i>K. pneumoniae</i> strains carrying <i>bla</i><sub><i>KPC−2</i></sub>. IS<i>26</i> is able to promote the evolution of resistance in the IncFII plasmid, and through copy-in cointegration or targeted conservative cointegration may result in the acquisition or loss of antibiotic resistance, which may affect clinical care and pose a public health risk.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

IS26 carrying blaKPC−2 mediates carbapenem resistance heterogeneity in extensively drug-resistant Klebsiella pneumoniae isolated from clinical sites

  • Zhiyun Guo,
  • Xia Qin,
  • Maokui Yue,
  • Lingling Wu,
  • Ning Li,
  • Jing Su,
  • Meijie Jiang

摘要

Background

Due to the widespread and irrational use of antibiotics, the emergence and prevalence of carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) have become a major challenge in controlling bacterial infections in hospitals. The blaKPC−2 gene located on mobile genetic elements has further complicated the control of resistant bacteria transmission.

Results

In this study, K. pneumoniae strains were isolated from blood cultures of patients. Using the Kirby-Bauer disk diffusion method, we found carbapenem resistance heterogeneity. The resistant subpopulation KPTA-R1 and the sensitive subpopulation KPTA-S1 were purified. Whole-genome sequencing revealed that the blaKPC−2 gene in KPTA-R1 was located on an IncFII plasmid (pKPC-R), within a composite transposon (PCTs) formed by two direct repeats of IS26 elements. The structure was identified as IS26-RecA-ISKpn27-blaKPC−2-ISKpn6-IS26. However, in KPTA-S1, a similar plasmid, pAR-S, lacked this segment. Sequence comparison analysis indicates that the deletion of this blaKPC−2 encoding sequence in this IncFII plasmid is associated with transposition activity mediated by IS26. Multi-sequence comparison of the plasmids showed that the IS26 transposon facilitated the sequence polymorphism of these plasmids.

Conclusion

This study reveals the key role of IS26-mediated transposition activity, through homologous recombination, in the emergence of carbapenem resistance heterogeneity in clinical K. pneumoniae strains carrying blaKPC−2. IS26 is able to promote the evolution of resistance in the IncFII plasmid, and through copy-in cointegration or targeted conservative cointegration may result in the acquisition or loss of antibiotic resistance, which may affect clinical care and pose a public health risk.